GetTopicDetailResponse(id=cd891269e286, topicName=有效載荷, introduction=, content=抗體偶聯(lián)藥物 有效載荷, image=null, comments=0, allHits=222, url=null, type=0, isShow=1, status=1, isAdmin=null, adminId=5395722, adminEncryptionId=cade5395722, adminName=梅斯管理員, createdBy=cade5395722, createdName=梅斯管理員, createdAvatar=, createdTime=Sat May 17 15:32:00 CST 2025, time=2025-05-17, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=504580, tagList=[TagDto(tagId=504580, tagName=有效載荷)], ipAttribution=上海, topicAdmin=0, lengthMark=0)
[GetTopicListResponse(id=2276039, encodeId=d3f922e6039e3, content=<a href='/topic/show?id=85de5518160' target=_blank style='color:#2F92EE;'>#抗體偶聯(lián)藥物#</a> <a href='/topic/show?id=cd891269e286' target=_blank style='color:#2F92EE;'>#有效載荷#</a>, objectTitle=ADC的非臨床和臨床毒性及相關(guān)影響因素, objectType=article, longId=889486, objectId=ba6088948659, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/doctor-is-working-at-the-hospital-P765AZE.jpg, objectUrl=/article/show_article.do?id=ba6088948659, replyNumber=0, likeNumber=17, createdTime=2025-08-04, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=ba6088948659, moduleTitle=ADC的非臨床和臨床毒性及相關(guān)影響因素, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=ba6088948659)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2265442, encodeId=fb1e226544235, content=<a href='/topic/show?id=85de5518160' target=_blank style='color:#2F92EE;'>#抗體偶聯(lián)藥物#</a> <a href='/topic/show?id=cd891269e286' target=_blank style='color:#2F92EE;'>#有效載荷#</a>, objectTitle=詳解ADC：從payload、linker到抗體偶聯(lián)技術(shù), objectType=article, longId=877854, objectId=08cd8e7854d8, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/doctor-writing-D3K6QME.jpg, objectUrl=/article/show_article.do?id=08cd8e7854d8, replyNumber=0, likeNumber=38, createdTime=2025-05-17, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=08cd8e7854d8, moduleTitle=詳解ADC：從payload、linker到抗體偶聯(lián)技術(shù), moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=08cd8e7854d8)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯管理員
2025-05-17發(fā)表于上海
